SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

Erstveröffentlichung

2022

Authors

Stathis, Anastasios

Mey, Ulrich

Schär, Sämi

Hitz, Felicitas

Pott, Christiane

et al.

Wissenschaftlicher Artikel

Published in

Blood Advances ; 6 (2022), 13. - S. 3911-3920. - ISSN 2473-9529. - eISSN 2473-9537

Link to publication

https://dx.doi.org/10.1182/bloodadvances.2021006520

Institutions

UKU. Institut für Experimentelle Tumorforschung

Subject headings

[Free subject headings]: NON-HODGKIN-LYMPHOMA | 1ST-LINE TREATMENT | BENDAMUSTINE-RITUXIMAB | RESPONSE ASSESSMENT | TUMOR BURDEN | INDOLENT | IBRUTINIB | BCL2
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record